Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911473 | Lung Cancer | 2012 | 6 Pages |
Abstract
NSCLC patients with LM exhibited diverse clinical outcomes rather than a uniformly poor prognosis. Systemic chemotherapy, especially EGFR TKIs in addition to intrathecal chemotherapy, might confer a survival benefit.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jin Hyun Park, Yu Jung Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jin-Haeng Chung, Jae Sung Kim, Jong Seok Lee,